ID

16022

Description

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00201682

Lien

https://clinicaltrials.gov/show/NCT00201682

Mots-clés

  1. 26/06/2016 26/06/2016 -
Téléchargé le

26 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Lymphocytic Leukemia NCT00201682

Eligibility Chronic Lymphocytic Leukemia NCT00201682

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have been previously treated cll/sll
Description

previously treated cll/sll

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0023449
must have cd20 expression
Description

cd20 expression

Type de données

boolean

Alias
UMLS CUI [1]
C0054946
ecog ps =<3
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
no prior campath-1h
Description

no prior campath-1h

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1178562
no active infection requiring antibiotics
Description

no active infection

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
no concurrent immunosuppressive therapy
Description

immunosuppressive therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0021079
no prior history demyelinating neurologic disease
Description

demyelinating neurologic disease

Type de données

boolean

Alias
UMLS CUI [1]
C0011303
no active viral hepatitis
Description

no active viral hepatitis

Type de données

boolean

Alias
UMLS CUI [1]
C0042721
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
no pregnant or breastfeeding women
Description

pregnant or lactating

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
ecog ps =4
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of >12 weeks
Description

life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
patients with bilirubin or creatinine>3.0 mg/dl
Description

high bilirubin or creatinine

Type de données

boolean

Alias
UMLS CUI [1]
C0005437
UMLS CUI [2]
C0201976

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00201682

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
previously treated cll/sll
Item
must have been previously treated cll/sll
boolean
C1514463 (UMLS CUI [1,1])
C0023449 (UMLS CUI [1,2])
cd20 expression
Item
must have cd20 expression
boolean
C0054946 (UMLS CUI [1])
ECOG performance status
Item
ecog ps =<3
boolean
C1520224 (UMLS CUI [1])
no prior campath-1h
Item
no prior campath-1h
boolean
C1514463 (UMLS CUI [1,1])
C1178562 (UMLS CUI [1,2])
no active infection
Item
no active infection requiring antibiotics
boolean
C0009450 (UMLS CUI [1])
immunosuppressive therapy
Item
no concurrent immunosuppressive therapy
boolean
C0009429 (UMLS CUI [1,1])
C0021079 (UMLS CUI [1,2])
demyelinating neurologic disease
Item
no prior history demyelinating neurologic disease
boolean
C0011303 (UMLS CUI [1])
no active viral hepatitis
Item
no active viral hepatitis
boolean
C0042721 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or lactating
Item
no pregnant or breastfeeding women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ECOG performance status
Item
ecog ps =4
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of >12 weeks
boolean
C0023671 (UMLS CUI [1])
high bilirubin or creatinine
Item
patients with bilirubin or creatinine>3.0 mg/dl
boolean
C0005437 (UMLS CUI [1])
C0201976 (UMLS CUI [2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial